Skip to main content

Nanogen's Plan to Divest Array Business Topped Most-Read GenomeWeb Daily News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Sept. 21.
1. Nanogen Mulls Sale or Closure of Microarray Business in Bid to Focus on Clinical Dx (from Sept. 18)
2. Alnylam and Merck Scuttle $120M-Plus RNAi Drug-Development Partnership (from Sept. 19)
3. NIH Sets Aside $574M to Expand Translational Research Consortium (from Sept. 19)
4. Clinton, Schumer Say VA's 'Stalling' on SUNY Genebank is Getting 'Ridiculous' (from Sept. 20)
5. Agilent to License ABI's RT-PCR Thermal Cycler IP as Part of Settlement (from Sept. 19)
The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.